Drug Makers to Settle Adalat Suit

A California judge has approved a settlement that could see Mississauga drug maker Biovail and two other pharmaceutical companies pay out $8.2 million (U.S.) to settle antitrust claims over the hypertension drug Adalat.
The Mississauga News